Page 506 - Company News

Pawan Hans secures Rs 2,000 cr contract for ONGC offshore helicopter ops

Pawan Hans will deploy made-in-India Dhruv NG helicopters, manufactured by Hindustan Aeronautics Ltd (HAL), to the Oil and Natural Gas Corporation

Nestle rolls out protein shots for US weight-loss drug users to curb hunger

The weekly weight-loss injections mimic an intestinal hormone called GLP-1 and curb people's appetite, promoting a feeling of fullness

Sembcorp Green bags 150 MW solar project with 300 MWh energy storage

The build-own-operate Project is part of a bid for 2GW Inter-state Transmission System (ISTS)-connected solar power projects with 4GWh of BESS, issued by SECI, a company statement said

Inox Wind secures 60 MW equipment supply order from Serentica Renewables

The power generated from this project will be supplied to Serentica's partners, including the Vedanta Group

Airtel become first private telco to connect Kupwara, Baramulla, Bandipore

The company said that it has deployed 15 mobile towers in Kupwara, Baramulla and Bandipore districts

Shriram Finance in talks to borrow $1.2 bn in offshore loan for sector

The non-bank financial company will offer a multitranche deal split across currencies such as the dollar, euro and dirham, the people said asking not to be identified

Nissan, Honda consider merger to take on world's biggest carmaker Toyota

Honda is considering several options including a merger, capital tie-up or the establishment of a holding company, Executive Vice President Shinji Aoyama said

Walmart's Flipkart has a tough battle ahead in India, a 2026 IPO likely

Flipkart is a stake Walmart has put down in a market where brick-and-mortar foreign retailers face stifling restrictions

State-owned REC raises Rs 2,195 crore via bonds of different maturities

Market participants said that the company did not raise the entire amount as the investors were demanding a higher coupon

Global logistics giant DP World expands Rewari terminal facility by 25%

This expansion will increase the monthly freight train handling capacity of the Pali-Rewari rail terminal by 25 per cent, from its current capacity of 192 trains to 240 trains, the company said

Barmer refinery & petrochem hub may begin processing crude next month

Mechanical completion of the project remains at 82%, commissioning to begin in March

Japan's auto giants Honda, Nissan Motor to soon begin merger talks

The two companies are looking to operate under a single holding company and are expected to soon sign a memorandum of understanding for the new merged entity

Use technology to drive progress, guard against misuse: Jeet Adani

Speaking at IIT Bombay's Techfest 2024, Adani, the 27-year old younger son of infrastructure magnate Gautam Adani, said the future of technology is both scary and exciting

Rupee woes fail to slow rise in India's billion-dollar unlisted firms

Ambani-owned firms, MNC subsidiaries claim top spots

magicpin introduces magicNOW 15 minute food delivery on a pilot basis

The food delivery firm will be initially launched in Bengaluru, Hyderabad, Mumbai, Chennai, Delhi-NCR, and Pune

'Imperial' trademark dispute: HC says yes to settlement among Akoi family

Hardev had alleged that Jasdev had unilaterally made changes to the trademark and moved the court to prevent its unauthorised use

Jindal Saw to acquire 31.2% stake in ReNew Green Energy for undisclosed sum

Jindal Saw further said it aims to complete the acquisition by May 31, 2025, or any other date as may be mutually decided between the parties

Temasek's arm Ramon gets CCI's approval to acquire stake in Speed JVco

Singapore-headquartered Temasek is an investment company. As of March 2024, the sovereign wealth fund owns a Singapore Dollar (SGD) 389 billion portfolio of assets

Sony to continue aggressive investment in country, says India MD Banerjee

SPNI is a part of Japanese conglomerate Sony Group Corporation that had announced to invest $1.575 billion while announcing the failed merger with Zee in September 2021

In relief for investors, Pfizer 2025 profit forecast in line with estimates

Shares of the drugmaker rose nearly 3 per cent to $25.98 in premarket trading after the company also said it was expecting 2025 sales of its Covid-19 vaccine and drug to be consistent